IPSEN Provides Update on Voting Rights and Share Capital for July 2026

Pharmaceutical company IPSEN has released its monthly update for July 2026, detailing the total number of voting rights and shares composing the company's share capital. This disclosure complies with French commercial law and financial market regulations.

As of July 31, 2026, IPSEN's share capital consists of 83,814,526 shares. The gross total number of voting rights stands at 132,132,996, while the net total, which excludes shares without voting rights, is 130,919,315. These figures are crucial for identifying threshold crossings as per the company's statutory obligations.

The company's shares are listed on Euronext Paris and can be identified using the ISIN code FR 0010259150 and LEI number 549300M6SGDPB4Z94P11. These identifiers are essential for investors and regulatory compliance.